Show All Results
Back
Back
Back
Show All Results
We have received FDA approval for a new oral therapy for the treatment of MS.
Neurology & ImmunologyCreative director Lydia Emily Archibald depicts the impact of multiple sclerosis on patients and caregivers through compelling artwork.
When is MS on your mind?Passionate about enriching the lives of patients and caregivers by offering therapies and support services.
Who we areThis website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re Ok with this. You can change which cookies are set at any time - and find out more about themin our cookie policy. Cookie Policy
You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.
You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.
If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website.
By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.